NEW HAVEN, Conn.--(BUSINESS WIRE)--Ikonisys, a leading provider of non-invasive, cell-based diagnostic solutions, announced today that it has established a clinical laboratory registered with the Centers for Medicare and Medicaid Services under the CLIA provisions and licensed by the state of Connecticut. The company’s clinical laboratory is intended to support proprietary and non-proprietary tests based on fluorescence in situ hybridization (FISH).
